-
Y Escabi,
L San Miguel,
T. Judd,
J Hertza,
J Nicholson,
W Schiff,
C Bell,
B Estes,
C Millikin,
P Shelton, [......],
D Wygant,
P Klonoff,
D Carone,
T O'Connor Pennuto,
A Kluck,
J Ball,
L Shahani,
J Thomspon,
A Bowles,
M Greiffenstein
[show abstract]
[hide abstract]
ABSTRACT: The evaluation of bilingual children is a complicated endeavor because there are various views of how bilingualism affects brain organization and functioning. Added to that is the challenge of determining language development of Hispanic children living in a monolingual Spanish-speaking home in a Spanish-speaking country, but mostly exposed to English language television programming and, in some cases, English language school curriculum. Our case will review the evaluation process of a 14-year-old Puerto Rican boy with previous diagnoses of expressive language disorder and Attention-deficit/Hyperactivity Disorder (ADHD). The neuropsychological evaluation revealed an IQ within the average range, with significant differences between the perceptual reasoning, verbal comprehension, and processing speed. The case will summarize performance in verbal, executive, and psycho-educational measures with a thorough review of his developmental history and the interpretation of these neuropsychological achievement and behavioral measures in light of other variables influencing his difficulties.
Archives of Clinical Neuropsychology 09/2010; 25(6):475-583. · 2.18 Impact Factor
-
J. Mason,
A. T. R. Axon,
D. Forman,
S. Duffett,
M. Drummond,
W. Crocombe,
R. Feltbower,
S. Mason,
J. Brown,
P. Moayyedi,
ON BEHALF OF THE LEEDS HELP STUDY GROUP
[show abstract]
[hide abstract]
ABSTRACT: Background:Economic models have suggested that population Helicobacter pylori screening and treatment may be a cost-effective method of reducing mortality from gastric cancer. These models are conservative as they do not consider that the programme may reduce health service peptic ulcer and other dyspepsia costs. We have evaluated the economic impact of population H. pylori screening and treatment over 2 years in a randomized controlled trial and have incorporated the results into an economic model exploring the impact of H. pylori eradication on peptic ulcer disease and gastric cancer.Methods:Subjects between the ages of 40 and 49 years were randomly invited to attend their local primary care centre. H. pylori status was evaluated by 13C-urea breath test and infected individuals were randomized to receive omeprazole, 20 mg b.d., clarithromycin, 250 mg b.d., and tinidazole, 500 mg b.d., for 7 days or identical placebos. Economic data on health service costs for dyspepsia were obtained from a primary care note review for the 2 years following randomization. These data were incorporated into a Markov model comparing population H. pylori screening and treatment with no intervention.Results:A total of 2329 of 8407 subjects were H. pylori positive: 1161 were randomized to receive eradication therapy and 1163 to receive placebo. The cost difference favoured the intervention group 2 years after randomization, but this did not reach statistical significance (£11.42 per subject cost saving; 95% confidence interval, £30.04 to – £7.19; P=0.23). Analysis by gender suggested a statistically significant dyspepsia cost saving in men (£27.17 per subject; 95% confidence interval, £50.01 to £4.32; P=0.02), with no benefit in women (– £4.46 per subject; 95% confidence interval, – £33.85 to £24.93). Modelling of these data suggested that population H. pylori screening and treatment for 1 000 000 45-year-olds would save over £6 000 000 and 1300 years of life. The programme would cost £14 200 per life year saved if the health service dyspepsia cost savings were the lower limit of the 95% confidence intervals and H. pylori eradication had only a 10% efficacy in reducing mortality from distal gastric cancer and peptic ulcer disease.Conclusions:Modelling suggests that population H. pylori screening and treatment are likely to be cost-effective and could be the first cost-neutral screening programme. This provides a further mandate for clinical trials to evaluate the efficacy of population H. pylori screening and treatment in preventing mortality from gastric cancer and peptic ulcer disease.
Alimentary Pharmacology & Therapeutics 02/2002; 16(3):559 - 568. · 3.77 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: A precision on-wafer VXI-based pulsed I-V measurement system
capable of rapid device characterization is presented. This system was
developed for I-V plane characterization of GaAs FETs, HBTs, and diodes
up to 100 volts. The pulsed I-V system is capable of pulsewidths under
200 nanoseconds with absolute current and voltage uncertainties less
than 2.5 percent over greater than 110 dB of dynamic range. Measurement
throughput is under 250 ms per I-V point. Accuracies are achieved by
applying “DC voltage substitution” calibration to a novel
pulser/sense instrument configuration
Microwave Symposium Digest, 1994., IEEE MTT-S International; 06/1994
